Imatinib mesylate (STI571) abrogates the resistance to doxorubicin in human K562 chronic myeloid leukemia cells by inhibition of BCR/ABL kinase-mediated DNA repair
Majsterek, Ireneusz and Sliwinski, Tomasz and Poplawski, Tomasz and Pytel, Dariusz and Kowalski, Michal and Slupianek, Artur and Skorski, Tomasz and Blasiak, Janusz
Source
Mutation Research/Genetic Toxicology and Environmental Mutagenesis, 603(1): 74—82, 2006